Acute bronchiolitis, an updated review;Bronquiolite aguda, uma revisão atualizada

Revista da Associacao Medica Brasileira

Volumn 53, Issue 2, 2007, Pages 182-188

  De Carvalho, Werther Brunow ^a   Johnston, Cíntia ^a,b   Fonseca, Marcelo Cunio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Edifício Flávia ^*  (Brazil)

Author keywords

Bronchiolitis; Pediatrical critical care; Respiratory syncytial virus; Respiratory tract infection; Respirotherapy

Indexed keywords

EID: 34250615387     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0104-42302007000200027     Document Type: Review

References (44)

1. Holman RC, Shay DK, Curns AT, Lingappa JR, Anderson LJ. Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J. 2003;22:483-90.
2. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143:S127-S32.
3. McCarthy CA, Hall CB. Respiratory syncytial vírus:concerns and control. Pediatr Rev. 2003;24:301-9.
4. Centers for Diseases Control. Prevention and control of influenza. MMWR Morb Mortal Wkly Rep. 2005;54:1-40.
5. Peltola V, Reunanen T, Ziegler T, Silvennoinen H, Heikkinen T. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis. 2005;41:1198-200.
6. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, et al. Influenza Special Investigations Team. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353(24):2559-67.
7. Sugaya N, Takeuchi Y. Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan. Clin Infect Dis. 2005;41:939-47.
8. Hillenbrand K. Antiviral therapy for influenza infections. Pediatr Rev. 2005;26:427-8.
9. Hall CB. Respiratory syncytial vírus and parainfluenza vírus. N Engl J Med. 2001;344:1917-28.
10. Reed G, Jewett PH, Thompson J, Tollefson S, Wright PF. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. J Infect Dis. 1997;175:807-13.
11. Langley JM. Adenoviruses. Pediatr Rev. 2005;26:244-9.
12. Kling S, Donninger H, Williams Z, Vermeulen J, Weinberg E, Latiff K, et al. Persistence of rhinovirus RNA after asthma exacerbation in children. Clin Exp Allergy. 2005;35:672-8.
13. Lemanske RF Jr, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005;116:571-7.
14. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. SARS Working Group. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953-66.
15. Hon KL, Leung CW, Cheng WT, Chan PK, Chu WC, Kwan YW, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet. 2003;361(9370):1701-3.
16. Van den Hoogen BG, Jong JC, Groen J, Kuiken T, Groot R, Fouchier RA, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7:719-24.
17. Semple MG, Cowell A, Dove W, Greensill J, McNamara PS, Halfhide C, et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis. 2005;191:382-6.
18. Van den Hoogen BG, Bestebroer TM, Osterhaus AD, Fouchier RA. Analysis of the genomic sequence of a human metapneumovirus. Virology. 2002;295:119-32.
19. Nissen MD, Siebert DJ, Mackay IM, Sloots TP, Withers SJ. Evidence of human metapneumovirus in Australian children. Med J Aust. 2002;176:188.
20. Boivin G, De Serres G, Cote S, Gilca R, Abed Y, Rochette L, et al. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis. 2003,9:634-40.
21. Garcia-Garcia ML, Calvo C, Martin F, Perez-Brena P, Acosta B, Casas I. Human metapneumovirus infections in hospitalised infants in Spain. Arch Dis Child. 2006;91:290-5.
22. Lind I, Gill JH, Calabretta NC. What are hospital admission criteria for infants with bronchiolitis? Clin Inquiries. 2006;55:67-9.
23. Brooks AM, McBride JT, McConnochie KM, Aviram M, Long C, Hall CB. Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics. 1999;104(3 Pt 1):463-7.
24. Black CP. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care. 2003;48:209-31.
25. Torres A Jr, Anders M, Anderson P, Heulitt MJ. Efficacy of metered-dose inhaler administration of albuterol in intubated infants. Chest. 1997;112:484-90.
26. Derish M, Hodge G, Dunn C, Ariagno R. Aerosolized albuterol improves airway reactivity in infants with acute respiratory failure from respiratory syncytial virus. Pediatr Pulmonol. 1998;26:12-20.
27. Barr FE, Patel NR, Newth CJ. The pharmacologic mechanism by which inhaled epinephrine reduces airway obstruction in respiratory syncytial virus-associated bronchiolitis. J Pediatr. 2000;136:699-700.
28. Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2004;(3):CD004878.
29. Van Woensel JB, Wolfs TF, Van Aalderen WM, Brand PL, Kimpen JL. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax. 1997;52:634-7.
30. Nasr SZ, Strouse PJ, Soskolne E, Maxvold NJ, Garver KA, Rubin BK, et al. Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis. Chest. 2001;120:203-8.
31. Merkus PJ, Hoog M, Van Gent R. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis. Eur Respir J. 2001;18:734-7.
32. Hendriks T, Hoog M, Lequin MH, Devos AS, Merkus PJ. DNase and atelectasis in non-cystic fibrosis pediatric patients. Crit Care. 2005;9:R351-6.
33. Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM. Heliox therapy in infants with acute bronchiolitis. Pediatrics. 2002;109:68-73.
34. Cambonie G, Milesi C, Fournier-Favre S, Counil F, Jaber S, Picaud JC, et al. Clinical effects of heliox administration for acute bronchiolitis in young infants. Chest. 2006;129:676-82.
35. Webb MSC, Martin JA, Cartlidge PHT. Chest physiotherapy in acute bronchiolitis. Arch Dis Child. 1985;60:1078-9.
36. Nicholas KJ, Dhouieb MO, Marshal TG. An evaluation of chest physiotherapy in the management of acute bronchiolitis. Changing clinical practice. Physiotherapy. 1999,85:669-74.
37. Bohe L, Ferrero ME, Cuestas E, Polliotto L, Genoff M. Indications of conventional chest physiotherapy in acute bronchiolitis. Medicina. (Buenos Aires) 2004;64:198-200.
38. Perrotta C, Ortiz Z, Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Databases Syst Rev. 2006;1.
39. Hoehn T, Krause M, Krueger M, Hentschel R. Treatment of respiratory failure with inhaled nitric oxide and high- frequency ventilation in an infant with respiratory syncytial virus pneumonia and bronchopulmonary dysplasia. Respiration. 1998;65:477-80.
40. Patel NR, Hammer J, Nichani S, Numa A, Newth CJ. Effect of inhaled nitric oxide on respiratory mechanics in ventilated infants with RSV bronchiolitis. Intensive Care Med. 1999;25:81-7.
41. Tibby SM, Hatherill M, Wright SM, Wilson P, Postle AD, Murdoch IA. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2000;162:1251-6.
42. Davison C, Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatr Crit Care Med. 2004;5:482-9.
43. Barbosa AP, Johnston C, Carvalho WB. Ventilação não-invasiva em neonatológica e pediatria. São Paulo: Editora Atheneu; 2007.p.1-273.
44. American Academy of Pediatrics. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of the respiratory syncytial infections (2003). [cited 2006]. Avaliable from: http//aappolicy.aappublications.org/cgi/reprint/pediatrics;112/ 6/1447.pdf.